D Danaher
| Market Cap | $135.26B |
| P/E Ratio | 38.00 |
| Forward P/E | 21.00 |
| Dividend Yield | 0.84% |
| Beta | 0.99 |
| 52W Range | $173.44 - $241.54 |
| # Hedge Funds | 11 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Hedge Fund Ownership
| Investor 13 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Pat Dorsey Dorsey Asset Management | 16.47% | $189.44M | 827,520 | Reduce 3.87% |
| Wallace Weitz Weitz Investment Management | 6.98% | $117.65M | 513,950 | Reduce 2.47% |
| Daniel Loeb Third Point LLC | 1.89% | $137.35M | 600,000 | Add 1100.00% |
| FPA Queens Road Small Cap Value Fund Bragg Financial Advisors | 0.50% | $15.39M | 67,229 | Add 1.08% |
| Bill & Melinda Gates Foundation Trust Gates Foundation Trust | 0.24% | $85.39M | 373,000 | — |
| Chuck Akre Akre Capital Management | 0.17% | $15.91M | 69,516 | Reduce 92.05% |
| Torray Funds Torray Investment Partners | 0.06% | $428.00K | 1,871 | — |
| David Katz Matrix Asset Advisors | 0.04% | $389.00K | 1,703 | Reduce 0.06% |
| Mairs & Power Growth Fund Mairs & Power Inc | 0.00% | $267.00K | 1,169 | Reduce 33.39% |
| Dodge & Cox Dodge & Cox | 0.00% | $3.77M | 16,450 | — |
| Bill Nygren Harris Associates LP | 0.00% | $517.00K | 2,261 | Reduce 31.86% |
| Lee Ainslie Maverick Capital | 0.00% | $0 | 0 | Sold |
| Viking Global Investors Viking Global Investors | 0.00% | $0 | 0 | Sold |
Insider Trading
| Insider Name of the company insider who made the trade 17 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Milosevich Gregory MExecutive Vice President | Sale | 1,320 | $208.01 | $274.57K | 19 Feb 2026 | 20 Feb 2026 |
| RALES MITCHELL PChairman of Exec. Committee | Sale | 35,899 | $230.27 | $8.27M | 25 Nov 2025 | 26 Nov 2025 |
| RALES MITCHELL PChairman of Exec. Committee | Sale | 4,726 | $231.19 | $1.09M | 25 Nov 2025 | 26 Nov 2025 |
| List Teri | Sale | 3,298 | $226.50 | $747.00K | 18 Nov 2025 | 19 Nov 2025 |
| Teri ListDirector | Sale | 3,298 | $226.50 | $747.00K | 18 Nov 2025 | 19 Nov 2025 |
| RALES MITCHELL PChairman of Exec. Committee | Sale | 23,359 | $220.15 | $5.14M | 12 Nov 2025 | 13 Nov 2025 |
| RALES MITCHELL PChairman of Exec. Committee | Sale | 254,553 | $218.27 | $55.56M | 12 Nov 2025 | 13 Nov 2025 |
| Ellis Brian WSenior Vice President - GC | Sale | 14,667 | $219.23 | $3.22M | 12 Nov 2025 | 13 Nov 2025 |
| RALES MITCHELL PChairman of Exec. Committee | Sale | 133,233 | $219.43 | $29.24M | 12 Nov 2025 | 13 Nov 2025 |
| RALES MITCHELL PChairman of Exec. Committee | Sale | 25,855 | $217.64 | $5.63M | 12 Nov 2025 | 13 Nov 2025 |
| Ellis Brian WSenior Vice President - GC | Sale | 7,109 | $219.21 | $1.56M | 12 Nov 2025 | 13 Nov 2025 |
| McGrew MatthewEVP & Chief Financial Officer | Sale | 16,172 | $214.62 | $3.47M | 11 Nov 2025 | 13 Nov 2025 |
| Couchara GeorgeannSVP, Human Resources | Sale | 998 | $210.31 | $209.89K | 10 Nov 2025 | 12 Nov 2025 |
| Couchara GeorgeannSVP, Human Resources | Sale | 4,176 | $210.44 | $878.81K | 10 Nov 2025 | 12 Nov 2025 |
| RALES MITCHELL PChairman of Exec. Committee | Sale | 68,128 | $217.17 | $14.80M | 31 Oct 2025 | 04 Nov 2025 |
| RALES MITCHELL PChairman of Exec. Committee | Sale | 223,449 | $216.26 | $48.32M | 31 Oct 2025 | 04 Nov 2025 |
| RALES MITCHELL PChairman of Exec. Committee | Sale | 308,423 | $215.67 | $66.52M | 31 Oct 2025 | 04 Nov 2025 |
Frequently Asked Questions
What is DHR stock price today?
Danaher (DHR) is currently trading at $191.12. The stock has a 52-week range of $173.44 to $241.54 and a market capitalization of $135.26B.
Is DHR a good stock to buy in 2026?
Danaher has a P/E ratio of 38.0 (forward P/E: 21.0), a dividend yield of 0.84%, and 1-year performance of -2.8%. 13 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling DHR stock?
There have been 17 insider transactions for DHR in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has DHR stock performed over the past year?
Danaher (DHR) has returned -2.8% over the past 12 months. The stock traded between $173.44 and $241.54 during this period, and is currently at $191.12.
Which hedge funds own DHR (Danaher)?
13 tracked hedge funds currently hold DHR in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is DHR's market cap and valuation?
Danaher (DHR) has a market capitalization of $135.26B. The trailing P/E ratio is 38.0 and forward P/E is 21.0. The stock is classified in the Healthcare sector.
What is DHR's revenue and profitability?
Danaher reported revenue of $24.57B with net income of $3.60B and a profit margin of 0.15%. The stock has a beta of 0.99.
What sector is DHR in and who are its biggest institutional holders?
Danaher (DHR) operates in the Healthcare sector. It is held by 13 tracked hedge funds. See the ownership table above for the complete list.